Ingo Mellinghoff
MD
Chair Department of Neurology
👥Biography 个人简介
Ingo Mellinghoff is a leader in the development of targeted therapy for gliomas. He led the INDIGO trial that established vorasidenib for IDH mutant low grade glioma. His laboratory studies molecular drivers of glioma and mechanisms of drug response. He is widely recognized for translating molecular insights into practice changing clinical trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ingo Mellinghoff 的研究动态
Follow Ingo Mellinghoff's research updates
留下邮箱，当我们发布与 Ingo Mellinghoff（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment